EUVIMEDOpdag EUVIMED
Fallbericht

CTBP1 In Brain Development: A Novel Variant c.107G>C,p.(R36P) Leads to a Distinct Neurodevelopmental Disorder

Takuma Nishijo, Kumiko Yanagi, Hidenori Ito, Nanako Hamada, Sadao Nakamura, Yasutsugu Chinen, Yasuyuki Fukuhara, Ikuko Iwamoto, Tadashi Kaname iD, Nobuhiko Okamoto, Koh-Ichi Nagata iD

Journal of Neurochemistry · 2026

DOI: 10.1111/jnc.70385 ↗

At a glance

Fallbericht in Journal of Neurochemistry, 2026. Written by Takuma Nishijo and 10 co-authors. Institution: Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Aichi, Japan. Major MEDLINE topics: Alcohol Oxidoreductases, DNA-Binding Proteins, Neurodevelopmental Disorders, Brain. 38 references. Funded by: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

CTBP1 (C‐terminal‐binding protein 1) is a multifunctional protein that acts as a transcriptional co‐repressor in the nucleus and a regulator of membrane fission in the cytoplasm. Variants in CTBP1 have been associated with neurodevelopmental disorder termed HADDTS (Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome; OMIM#617915). However, the pathophysiological mechanism of this genetic disorder remains unclear. Whole exome sequencing was performed on a 20‐year‐old male patient with severe mental retardation, atrial septal defect, ataxia, and dysmorphic features. The patient was found to have a de novo missense variant, c.107G>C,p.(R36P), within the PLDLS (Pro‐Leu‐Asp‐Leu‐Ser) binding cleft of CTBP1. However, the patient did not fulfill the diagnostic criteria for HADDTS. Therefore, the pathophysiological significance of this variant was investigated in vitro and in vivo, comparing it with p.R342W, a recurrent pathogenic variant in HADDTS. Transient expression of the p.R36P and p.R342W variants reduced the number and total length of dendrites in primary cultured hippocampal neurons. In vivo acute expression of them caused a migration delay of excitatory neurons and disrupted both dendritic arborization and spine formation during corticogenesis. Subsequent electrophysiological analyses suggested that these variants reduced excitatory synaptic transmission. Additionally, the p.R36P variant, but not p.R342W, reduced the excitability of layer II/III pyramidal neurons. We also report two new cases with the p.R342W variant that meet the diagnostic criteria for HADDTS. Our results show that CTBP1 plays an essential role in brain development and that the novel variant may cause a new developmental disorder distinct from HADDTS. image

Subjects

MeSH terms (MEDLINE)

Alcohol OxidoreductasesDNA-Binding ProteinsNeurodevelopmental DisordersBrainHumansMaleAnimalsYoung AdultNeurodevelopmentMutation, Missense

Author keywords

CTBP1cortical neuroncorticogenesisdevelopmentintellectual disability

Substances

Alcohol OxidoreductasesDNA-Binding ProteinsC-terminal binding protein

Authors and institutions

  • Department of Molecular Neurobiology, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Aichi, Japan.
  • Department of Genome Medicine, National Center for Child Health and Development, Tokyo, Japan.
  • Department of Child Health and Welfare (Pediatrics), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Division of Medical Genetics, National Center for Child Health and Development, Tokyo, Japan.
  • Departments of Medical Genetics, Osaka Women's and Children's Hospital, Izumi, Japan.
  • Departments of Molecular Medicine, Research Institute, Osaka Women's and Children's Hospital, Izumi, Japan.

ORCID profiles: Tadashi Kaname, Koh-Ichi Nagata

Funding

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Cite

APA

Nishijo, T., Yanagi, K., Ito, H., Hamada, N., Nakamura, S., Chinen, Y., Fukuhara, Y., Iwamoto, I., Kaname, T., Okamoto, N., & Nagata, K. I. (2026). CTBP1 In Brain Development: A Novel Variant c.107G>C,p.(R36P) Leads to a Distinct Neurodevelopmental Disorder. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70385

Vancouver

Nishijo T, Yanagi K, Ito H, Hamada N, Nakamura S, Chinen Y, et al. CTBP1 In Brain Development: A Novel Variant c.107G>C,p.(R36P) Leads to a Distinct Neurodevelopmental Disorder. Journal of Neurochemistry. 2026. doi:10.1111/jnc.70385

BibTeX
@article{Nishijo2026,
  author = {Nishijo, Takuma and Yanagi, Kumiko and Ito, Hidenori and Hamada, Nanako and Nakamura, Sadao and Chinen, Yasutsugu and Fukuhara, Yasuyuki and Iwamoto, Ikuko and Kaname, Tadashi and Okamoto, Nobuhiko and Nagata, Koh-Ichi},
  title = {CTBP1 In Brain Development: A Novel Variant c.107G>C,p.(R36P) Leads to a Distinct Neurodevelopmental Disorder},
  journal = {Journal of Neurochemistry},
  year = {2026},
  doi = {10.1111/jnc.70385}
}
Start for free →